Thailand buys 50,000 courses of Pfizer anti-viral drug Paxlovid


BANGKOK (The Nation/Asia News Network): The Medical Services Department on Thursday (March 24) signed a contract to purchase 50,000 treatment courses of Paxlovid drug with Pfizer Thailand for Covid-19 patients in risk groups.

Department director-general Somsak Akkasilp took part in the online contract signing with Deborah Seifert, country manager of Pfizer Thailand and Indochina.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , covid-19 , anti-viral , Pfizer , drug , paxlovid

Next In Aseanplus News

Thailand's children are falling behind and the nation's future depends on what happens next
Some of the deadly earthquakes in the Philippines
Singapore PM on population, AI-enabled disinformation and whether a Cabinet reshuffle is coming
North Korea and China leaders agree to boost ties at Pyongyang summit
FBM KLCI edges lower in early trade amid cautious sentiment
Ringgit opens higher against US dollar, most major currencies
Retired HK actress Cherie Chung, 66, stuns fans with striking looks in rare public outing
S&P 500, Nasdaq end up as tech, chipmakers rebound
India detains and deports 5,000 Bangladeshis
Venus and Jupiter gather for ‘cosmic kiss’

Others Also Read